Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05124899 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products
A NA study of Sunscreening Agents, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05124899: Completed NA study of Sunscreening Agents, sponsored by HALEON.
NCT05124899 is a NA study of Sunscreening Agents that has completed, run by HALEON. The registered enrollment target is 15 participants, below the 80-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05124899, a NA study of Sunscreening Agents, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the 80-Minute Water Resistant SPF of three sunscreen products (ChapStick Active Performance \[CAP\] UnScented, CAP Herbal Mint Flavour and CAP Mountain Berry Flavour) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).
Primary Outcome
SPF values for each test product and the SPF standard were first calculated for each individual participant:SPFi = MEDp/MEDuR (p=protected \[treated\] site; u=unprotected \[untreated\] site). The arithmetic mean SPF, standard deviation (SD) and standard error (SE) were then calculated separately for each test product and the SPF standard from valid SPFi data: SPF = (ΣSPFi)/n; SD = √\[(ΣSPFi\^2) - ((ΣSPFi)\^2/n) /(n-1))\]; SE = SD/√n (n = no. participants providing valid test results). For SPF de
Conditions Studied
Interventions
- DRUG CAP UnScented
- DRUG CAP Herbal Mint
- DRUG CAP Mountain Berry
- DRUG SPF Standard Sunscreen
Study Locations (1)
North Carolina
- GSK Investigational Site - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-11-16 |
| Est. Completion | 2021-12-18 |
| Phase | NA |
What the finished NCT05124899 record still lists
NCT05124899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 80-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 4 interventions - of which CAP UnScented is the first listed.
NCT05124899 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05124899 about?
NCT05124899 is a clinical study titled "Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products". The purpose of this study is to determine the 80-Minute Water Resistant SPF of three sunscreen products (ChapStick Active Performance \[CAP\] UnScented, CAP Herbal Mint Flavour and CAP Mountain Berry Flavour) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011)...
What is the current status of trial NCT05124899?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-11-16. Estimated completion is 2021-12-18.
What conditions does trial NCT05124899 study?
This clinical trial studies the following conditions: Sunscreening Agents.
What interventions are being tested in trial NCT05124899?
The interventions under investigation include: CAP UnScented (DRUG), CAP Herbal Mint (DRUG), CAP Mountain Berry (DRUG), SPF Standard Sunscreen (DRUG).
Who is sponsoring clinical trial NCT05124899?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05124899 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreening Agents
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05124899's enrollment target sits among peer trials
15 9th of 21 higher than 13 of 21 other Sunscreening Agents trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sunscreening Agents trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Sunscreen Dispensers in Parks Visited by Teenagers
ACTIVE NOT RECRUITING · NA
-
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Three Sunscreen Products
COMPLETED · NA
-
To Assess the Safety of a Sunscreen Product
COMPLETED · NA
-
Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)
COMPLETED · NA
-
Sun Protection Factor Assay (SPF Assay 204/2016)
COMPLETED · NA
-
18794 - Human Photo Toxicity Test
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI